Haemonetics (HAE) Debt to Equity (2010 - 2026)

Haemonetics' Debt to Equity history runs 17 years deep, the most recent figure standing at $1.54 for Q1 2026.

• In Q1 2026, Debt to Equity rose 3.06% year-over-year to $1.54; the TTM figure through Mar 2026 stood at $1.54 (up 3.06% YoY), while the FY2026 annual figure was $1.54, up 3.06% from the prior year.
• Debt to Equity was $1.54 for Q1 2026 at Haemonetics, up from $1.34 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $1.54 in Q1 2026 to a low of $0.84 in Q1 2024.
• Historically, Debt to Equity has averaged $1.16 across 5 years, with a median of $1.09 in 2022.
• The sharpest annual moves came in 2022 and 2023: Debt to Equity soared 146.89% in 2022, then slipped 23.96% in 2023.
• A 5-year view of Debt to Equity shows it stood at $0.99 in 2022, then fell by 6.6% to $0.92 in 2023, then surged by 46.35% to $1.35 in 2024, then dropped by 0.51% to $1.34 in 2025, then advanced by 14.44% to $1.54 in 2026.
• The last three Debt to Equity figures came in at $1.54 (Q1 2026), $1.34 (Q4 2025), and $1.44 (Q3 2025), per Business Quant data.